The global vutrisiran industry is experiencing unprecedented growth, with market valuation rising from USD 671.96 Million in 2023 to an anticipated USD 2,087 Million by 2033, registering a robust CAGR of 12% during the forecast period from 2023 to 2033. This impressive expansion underscores the pivotal role of vutrisiran in addressing unmet medical needs for hereditary …